Idexx Laboratories IDXX Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $4.3B+10.4% | $3.9B+6.5% | $3.66B+8.7% | $3.37B+4.7% | ||
| $1.64B+8.3% | $1.52B+3.2% | $1.47B+7.9% | $1.36B+2.8% | ||
| $2.66B+11.8% | $2.38B+8.6% | $2.19B+9.3% | $2B+6.1% | ||
| 61.8%+0.8pp | 61%+1.2pp | 59.8%+0.3pp | 59.5%+0.8pp | ||
| $251.21M+14.3% | $219.79M+15.1% | $190.95M-25.1% | $254.82M+58.3% | ||
| $643.55M+9.4% | $588.51M+4.0% | $566.07M+7.9% | $524.51M+7.8% | ||
| $404.79M-8.5% | $442.29M+31.7% | $335.83M+2.9% | $326.25M+5.4% | ||
| $1.3B+3.9% | $1.25B+14.4% | $1.09B-1.2% | $1.11B— | ||
| $1.36B+20.5% | $1.13B+2.8% | $1.1B+22.1% | $898.77M-3.6% | ||
| 31.6%+2.7pp | 29%-1.0pp | 30%+3.3pp | 26.7%-2.3pp | ||
| $38.85M+24.5% | $31.21M-25.0% | $41.58M+4.3% | $39.86M+33.7% | ||
| $1.32B+19.3% | $1.11B+4.6% | $1.06B+23.4% | $859.97M-4.7% | ||
| $264.73M+19.3% | $221.96M+2.7% | $216.13M+19.5% | $180.88M+14.6% | ||
| $1.06B+19.3% | $887.87M+5.1% | $845.04M+24.4% | $679.09M-8.8% | ||
| 24.6%+1.8pp | 22.8%-0.3pp | 23.1%+2.9pp | 20.2%-3.0pp | ||
| $13.08+22.6% | $10.67+6.1% | $10.06+25.1% | $8.04-6.6% | ||
| $1.51B+19.6% | $1.26B+3.8% | $1.21B+19.9% | $1.01B-2.5% | ||
| 35%+2.7pp | 32.3%-0.8pp | 33.1%+3.1pp | 30%-2.2pp | ||
| $1.36B+20.5% | $1.13B+2.8% | $1.1B+22.1% | $898.77M-3.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Idexx Laboratories's revenue?
- Idexx Laboratories (IDXX) generated $4.4B in revenue over the trailing twelve months, up 13.1% year over year.
- Is Idexx Laboratories profitable?
- Idexx Laboratories reported $1.1B in net income over the trailing twelve months, a 24.6% net margin.
- What are Idexx Laboratories's profit margins?
- Gross margin is 62.1% and operating margin is 31.6%, with a 24.6% net margin.
- What is Idexx Laboratories's earnings per share?
- Idexx Laboratories's diluted EPS over the trailing twelve months is $13.59.
- Where does Idexx Laboratories's income statement data come from?
- Every line is extracted from Idexx Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
